These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18262403)

  • 1. Improving coverage and scale-up of HIV prevention, treatment and care for injecting drug users: moving the agenda forward.
    Sharma M; Burrows D; Bluthenthal RN
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S1-4. PubMed ID: 18262403
    [No Abstract]   [Full Text] [Related]  

  • 2. Learning from HIV epidemics among injecting drug users.
    Jarlais DC
    Int J Drug Policy; 2010 Mar; 21(2):97-9. PubMed ID: 20018500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coverage to curb the emerging HIV epidemic among injecting drug users in Pakistan: delivering prevention services where most needed.
    Emmanuel F; Fatima M
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S59-64. PubMed ID: 18281206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Legal harm reduction among intravenous drug users.
    Kongsakon R; Pocham N
    J Med Assoc Thai; 2006 Sep; 89(9):1545-50. PubMed ID: 17100399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A primary healthcare clinic in a needle syringe program may contribute to HIV prevention by early detection of incident HIV in an injecting drug user.
    Islam MM; Grummett S; White A; Reid SE; Day CA; Haber PS
    Aust N Z J Public Health; 2011 Jun; 35(3):294-5. PubMed ID: 21627733
    [No Abstract]   [Full Text] [Related]  

  • 6. Measuring effectiveness of needle and syringe exchange programs for prevention of HIV among injecting drug users: Response to Amundsen.
    Maher L; Iversen J; Kaldor J
    Addiction; 2006 Dec; 101(12):1834-6. PubMed ID: 17156184
    [No Abstract]   [Full Text] [Related]  

  • 7. Setting targets for universal access to HIV prevention, treatment and care for injecting drug users (IDUs): towards consensus and improved guidance.
    Donoghoe MC; Verster A; Pervilhac C; Williams P
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S5-14. PubMed ID: 18243681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a harm-reduction programme on soft tissue infections among injecting drug users of Kolkata, India.
    Bhattacharya MK; Naik TN; Palit A; Bhattacharya SK
    J Health Popul Nutr; 2006 Mar; 24(1):121-2. PubMed ID: 16796159
    [No Abstract]   [Full Text] [Related]  

  • 9. HIV prevention and psychoactive drug use: a research agenda.
    Des Jarlais DC; Semaan S
    J Epidemiol Community Health; 2009 Mar; 63(3):191-6. PubMed ID: 19218258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Association of Nurses in AIDS Care. Position paper on harm reduction and HIV care for drug users: integrating harm-reduction methods and HIV care.
    Fisk SN
    J Assoc Nurses AIDS Care; 1998; 9(3):19-24. PubMed ID: 9589418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug users embrace Vancouver site.
    AIDS Patient Care STDS; 2004 Mar; 18(3):186. PubMed ID: 15112644
    [No Abstract]   [Full Text] [Related]  

  • 12. Injection drug use in Rural Iran: integrating HIV prevention into iran's rural primary health care system.
    Mojtahedzadeh V; Razani N; Malekinejad M; Vazirian M; Shoaee S; Saberi Zafarghandi MB; Hernandez AL; Mandel JS
    AIDS Behav; 2008 Jul; 12(4 Suppl):S7-12. PubMed ID: 18521737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coverage of HIV prevention programmes for injection drug users: confusions, aspirations, definitions and ways forward.
    Sharma M; Burrows D; Bluthenthal R
    Int J Drug Policy; 2007 Mar; 18(2):92-8. PubMed ID: 17689351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexisting or conjoined: the growth of the international drug users' movement through participation with International Harm Reduction Association Conferences.
    Byrne J; Albert ER
    Int J Drug Policy; 2010 Mar; 21(2):110-1. PubMed ID: 19942422
    [No Abstract]   [Full Text] [Related]  

  • 15. [Services for drug users. Making a difference in many lives].
    Medellín JM
    Sidahora; 2005; ():12-7. PubMed ID: 16634157
    [No Abstract]   [Full Text] [Related]  

  • 16. HIV, drug users and community prevention.
    Addiction; 1995 Jul; 90(7):997-8. PubMed ID: 7663324
    [No Abstract]   [Full Text] [Related]  

  • 17. A review of barriers and facilitators of HIV treatment among injection drug users.
    Wood E; Kerr T; Tyndall MW; Montaner JS
    AIDS; 2008 Jul; 22(11):1247-56. PubMed ID: 18580603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlling HIV among injecting drug users: the current status of harm reduction.
    Wodak A
    HIV AIDS Policy Law Rev; 2006 Dec; 11(2-3):77-80. PubMed ID: 17375432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug substitution therapy: a new approach in preventing the spread of HIV/AIDS in Malaysia.
    Razali SM
    Trop Doct; 2008 Apr; 38(2):109-10. PubMed ID: 18453507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing information: using systematic data collection to estimate process and impact indicators related to harm reduction services in Myanmar.
    Baldwin S; Boisen N; Power R
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S74-9. PubMed ID: 18281205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.